Raymond James Financial »

Elicio Therapeutics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $119k 11k 10.69
2025-06-30 $46k 6.0k 7.72

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p500 Etf (IVV)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Elicio Therapeutics

Knoll Capital Management
Vanguard Capital Management
Susquehanna International
Balyasny Asset Management
Geode Capital Management
Renaissance Technologies
Jane Street
Millennium Management
Citadel Advisors
Marshall Wace
Vanguard Fiduciary Trust
Northern Trust
Goldman Sachs Group
683 Capital Management
State Street Corporation

View all funds holding Elicio Therapeutics